Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Kashyap is Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine and Staff Physician in the Department of Endocrinology at Cleveland Clinic since 2004. She graduated from the University of California at Irvine College of Medicine and proceeded to complete a medical residency at George Washington University Hospital and St. Elizabeth’s Medical Center in Boston. She completed her clinical fellowship in Endocrinology, Diabetes and Metabolism at UCLA/Greater Los Angeles VA Medical Center and a post-doctoral metabolism research fellowship at the University of Texas Health Science Center.
Dr. Kashyap's clinical and research focus is on insulin resistance, type 2 diabetes and the endocrine/hormonal effects of bariatric surgery. She is a recipient of clinical research grants from the American Diabetes Association and the National Institute of Health and serves on both the ADA scientific session program committee and Endocrine Society board review committee. She is also a lead investigator of a randomized control trial to examine bariatric surgery versus advanced medical therapy for type 2 diabetes in the setting of modest obesity. She has over 50 publications in high impact journals including New England Journal of Medicine, Diabetes, Diabetes Care, Journal of Clinical Endocrinology and Metabolism and American Journal of Physiology. She has lectured to national societies including American College of Physicians and American Diabetes Association and the European Association for the Study of Diabetes. Dr. Kashyap has a number of teaching awards from Cleveland Clinic Lerner College of Medicine including the Scholarship in Teaching Award from Case Western Reserve University. Dr. Kashyap has trained a number of medical students, residents and fellows and enjoys teaching evidence based medicine.
Diabetes, general endocrinology, hyperlipidemia, insulin resistance, cardiovascular risk prevention, lipid disorders, metabolic syndrome, metabolism, obesity
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/20/2015, Dr. Kashyap has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.